Utilizing a PTPN22 gene signature to predict response to targeted therapies in rheumatoid arthritis

Journal of Autoimmunity - Tập 101 - Trang 121-130 - 2019
Hui-Hsin Chang1,2, Ching-Huang Ho1,2, Beverly Tomita1,2, Andrea A. Silva1,2, Jeffrey A. Sparks1,2, Elizabeth W. Karlson1,2, Deepak A. Rao1,2, Yvonne C. Lee1,2, I-Cheng Ho1,2
1Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States
2Harvard Medical School, Boston, MA, United States

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Journal of Autoimmunity

Tập 101

121-130

Thông tin tác giả